| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1010041872 |
| P356 | DOI | 10.1007/S001250050666 |
| P698 | PubMed publication ID | 9049484 |
| P50 | author | Gilberto Velho | Q44259397 |
| Graeme I. Bell | Q60572593 | ||
| P2093 | author name string | Weber IT | |
| Bellanné-Chantelot C | |||
| Deschamps I | |||
| Froguel P | |||
| Timsit J | |||
| Lipkind GM | |||
| Passa P | |||
| Robert JJ | |||
| Pilkis SJ | |||
| Marotta D | |||
| Blanché H | |||
| Pardini VC | |||
| Vaxillaire M | |||
| P433 | issue | 2 | |
| P304 | page(s) | 217-224 | |
| P577 | publication date | 1997-02-01 | |
| P1433 | published in | Diabetologia | Q5270140 |
| P1476 | title | Identification of 14 new glucokinase mutations and description of the clinical profile of 42 MODY-2 families | |
| P478 | volume | 40 |
| Q45281560 | A genetic and physiological study of impaired glucose homeostasis control in C57BL/6J mice |
| Q50554021 | Alx3-deficient mice exhibit decreased insulin in beta cells, altered glucose homeostasis and increased apoptosis in pancreatic islets. |
| Q54613502 | Animal model of human maturity onset diabetes of the young--type 2: similar but different? |
| Q36269724 | Association of prediabetes-associated single nucleotide polymorphisms with microalbuminuria |
| Q36210972 | Association with nitric oxide synthase on insulin secretory granules regulates glucokinase protein levels |
| Q40934358 | Cell-biological assessment of human glucokinase mutants causing maturity-onset diabetes of the young type 2 (MODY-2) or glucokinase-linked hyperinsulinaemia (GK-HI). |
| Q24291611 | Characterization of glucokinase-binding protein epitopes by a phage-displayed peptide library. Identification of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase as a novel interaction partner |
| Q41862149 | Chronic Mild Hyperglycemia in GCK-MODY Patients Does Not Increase Carotid Intima-Media Thickness. |
| Q35997281 | Clinical features and treatment of maturity onset diabetes of the young (MODY). |
| Q37095214 | Clinical implications of a molecular genetic classification of monogenic beta-cell diabetes |
| Q42714781 | Clinically-Defined Maturity Onset Diabetes of the Young in Omanis: Absence of the common Caucasian gene mutations |
| Q34610919 | Contrasting molecular population genetics of four hexokinases in Drosophila melanogaster, D. simulans and D. yakuba. |
| Q37403160 | Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications. |
| Q36811796 | Differential expression of genes and changes in glucose metabolism in the liver of liver-specific glucokinase gene knockout mice. |
| Q28479050 | Functional characterization of MODY2 mutations highlights the importance of the fine-tuning of glucokinase and its role in glucose sensing |
| Q41713452 | GCK gene mutations are a common cause of childhood-onset MODY (maturity-onset diabetes of the young) in Turkey |
| Q39828890 | GCK-MODY in the US National Monogenic Diabetes Registry: frequently misdiagnosed and unnecessarily treated |
| Q33899140 | Genetic Counseling for Diabetes Mellitus |
| Q54973025 | Genetic Testing of Maturity-Onset Diabetes of the Young Current Status and Future Perspectives. |
| Q58025244 | Genetic epidemiology of MODY in the Czech republic: new mutations in the MODY genes HNF-4alpha, GCK and HNF-1alpha |
| Q35259684 | Genetic testing for maturity onset diabetes of the young in childhood hyperglycaemia. |
| Q40453081 | Genetic testing for maturity onset diabetes of the young: uptake, attitudes and comparison with hereditary non-polyposis colorectal cancer. |
| Q36423339 | Genetics of macrovascular complications in diabetes |
| Q43245993 | Gestational diabetes mellitus: primum non nocere. |
| Q34947569 | Glucagon-like peptide 1 stimulates post-translational activation of glucokinase in pancreatic beta cells |
| Q34266132 | Glucokinase (GCK) mutations in hyper- and hypoglycemia: Maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemia of infancy |
| Q38262676 | Glucokinase MODY and implications for treatment goals of common forms of diabetes |
| Q35250931 | Glucokinase and IRS-2 are required for compensatory beta cell hyperplasia in response to high-fat diet-induced insulin resistance. |
| Q28472433 | Glucokinase gene mutations: structural and genotype-phenotype analyses in MODY children from South Italy |
| Q34023089 | Less but better: cardioprotective lipid profile of patients with GCK-MODY despite lower HDL cholesterol level |
| Q92854508 | Maturity-Onset Diabetes of the Young (MODY) in Portugal: Novel GCK, HNFA1 and HNFA4 Mutations |
| Q92276315 | Maturity-onset diabetes of the young (MODY): current perspectives on diagnosis and treatment |
| Q37364911 | Maturity-onset diabetes of the young in children with incidental hyperglycemia: a multicenter Italian study of 172 families |
| Q36560518 | Metabolite profiling reveals normal metabolic control in carriers of mutations in the glucokinase gene (MODY2) |
| Q77735613 | Molecular Genetics of Maturity-onset Diabetes of the Young |
| Q38306165 | Molecular genetic testing of patients with monogenic diabetes and hyperinsulinism |
| Q24653018 | Molecular physiology of mammalian glucokinase |
| Q28066434 | Monogenic diabetes and pregnancy |
| Q36691238 | Monogenic diabetes in children and young adults: Challenges for researcher, clinician and patient |
| Q37590415 | Monogenic diabetes: a diagnostic algorithm for clinicians |
| Q33576453 | Naturally occurring glucokinase mutations are associated with defects in posttranslational S-nitrosylation |
| Q27024024 | Pathogenesis of the metabolic syndrome: insights from monogenic disorders |
| Q38701664 | Phenotype Heterogeneity in Glucokinase-Maturity-Onset Diabetes of the Young (GCK-MODY) Patients |
| Q46963852 | Phenotypic heterogeneity between different mutations of MODY subtypes and within MODY pedigrees |
| Q28080643 | Present status of clinical deployment of glucokinase activators |
| Q51486468 | Prevalence and clinical phenotype of the p.Val226Met glucokinase gene mutation in French Canadians in Quebec, Canada. |
| Q33691222 | Quantitative mass spectrometry of diabetic kidney tubules identifies GRAP as a novel regulator of TGF-beta signaling |
| Q64119960 | The APOE3-Leiden Heterozygous Glucokinase Knockout Mouse as Novel Translational Disease Model for Type 2 Diabetes, Dyslipidemia, and Diabetic Atherosclerosis |
| Q90316040 | The Impact of Biomarker Screening and Cascade Genetic Testing on the Cost-Effectiveness of MODY Genetic Testing |
| Q96303797 | Update on clinical screening of maturity-onset diabetes of the young (MODY) |
| Q37605708 | Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia |
| Q31120060 | Use of HbA1c in the identification of patients with hyperglycaemia caused by a glucokinase mutation: observational case control studies |
| Q45155023 | Visualising insulin secretion. The Minkowski Lecture 2004. |
| Q38816600 | When is it MODY? Challenges in the Interpretation of Sequence Variants in MODY Genes |
Search more.